ArticleCurrent oncology (Toronto, Ont.)2024
Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer.
Colleen Mackenzie, Jasna Deluce, Morgan Black, Emma Churchman, Eric Winquist, Scott Ernst, David T Laidley, Matthew Parezanovic, Kylea Potvin, Ricardo Fernandes
Abstract read
In one paragraphArticle in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Colleen MackenzieSchulich School of Medicine and Dentistry, Western University, London, ON N6A 3K7, Canada.
Morgan BlackVerspeeten Family Cancer Centre, Victoria Hospital, London Health Sciences Centre, London, ON N6A 5W9, Canada.ORCID 0000-0002-7087-7727 Emma ChurchmanVerspeeten Family Cancer Centre, Victoria Hospital, London Health Sciences Centre, London, ON N6A 5W9, Canada.ORCID 0000-0001-8684-6338 Eric WinquistVerspeeten Family Cancer Centre, Victoria Hospital, London Health Sciences Centre, London, ON N6A 5W9, Canada.ORCID 0000-0002-8829-5979 Scott ErnstVerspeeten Family Cancer Centre, Victoria Hospital, London Health Sciences Centre, London, ON N6A 5W9, Canada.
David T LaidleyMedical Imaging Department, Division of Nuclear Medicine, Victoria Hospital, London Health Sciences Centre, Western University, London, ON N6A 3K7, Canada.
Matthew ParezanovicVerspeeten Family Cancer Centre, Victoria Hospital, London Health Sciences Centre, London, ON N6A 5W9, Canada.
Kylea PotvinVerspeeten Family Cancer Centre, Victoria Hospital, London Health Sciences Centre, London, ON N6A 5W9, Canada.
Ricardo FernandesVerspeeten Family Cancer Centre, Victoria Hospital, London Health Sciences Centre, London, ON N6A 5W9, Canada.ORCID 0000-0002-7195-8246 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Prostatic Neoplasms, Castration-ResistantRadiumAgedBone NeoplasmsHumansMaleMiddle AgedRadioisotopesRetrospective StudiesTreatment OutcomeRadioisotopesRadiumRadium-223radium Ra 223 dichloridebone metastasiscastration-resistant prostate cancerclinical outcomesradium-223
Identifiers
PMID39590111
PMCPMC11592830
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390